Evidence map›Paper›PMID 29110192›Full record

ArticleJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract2018

Endoscopic Sleeve Gastroplasty, Laparoscopic Sleeve Gastrectomy, and Laparoscopic Band for Weight Loss: How Do They Compare?

Aleksey A Novikov, Cheguevara Afaneh, Monica Saumoy, Viviana Parra, Alpana Shukla, Gregory F Dakin, Alfons Pomp, Enad Dawod, Shawn Shah, Louis J Aronne and 1 more

2 registry-linked trialsAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 60 papers, 15 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 15 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04006002 terminatednot on this mapstarted 2019, after this paper: background citation

A Pilot Study to Compare Anatomic, Physiologic, Metabolic and Weight Changes After Standard of Care Endoscopic Gastric Restrictive Bariatric Interventions vs. Standard of Care Laparoscopic Sleeve Gastrectomy

Typeobservational_patient_registrySponsorNorthwell HealthRan2019 to 2022Enrolled4ConditionsWeight Loss, RefluxArmsMetabolic and Hormonal profile
NCT06339320 narecruitingnot on this mapstarted 2024, after this paper: background citation

Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity

TypeinterventionalSponsorThe Methodist Hospital Research InstituteRan2024 to 2033Enrolled150ConditionsEndoscopic Sleeve Gastroplasty, ObesityArmsEndoscopic Sleeve Gastroplasty (ESG), Apollo OverStitch endoscopic suturing device
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 15 syntheses or guidelines pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2020
    Pooled it
  14. Pooled it
  15. Pooled it
  16. Trial
  17. Trial
  18. Article
  19. Article
  20. Endoscopic sleeve gastrectomyWorld journal of gastrointestinal pharmacology and therapeutics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Aleksey A NovikovDivision of Gastroenterology and Hepatology, Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY, 10021, USA.
Cheguevara AfanehDivision of Metabolic and Bariatric Surgery, 520 East 70th Street, Starr 8, New York, NY, 10021, USA.
Monica SaumoyDivision of Gastroenterology and Hepatology, Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY, 10021, USA.
Viviana ParraClínica Universitaria Colombia, Bogotá, Colombia.
Alpana ShuklaDivision of Endocrinology, Weill Cornell Medicine, 525 E. 68th Street, New York, NY, 10021, USA.
Gregory F DakinDivision of Metabolic and Bariatric Surgery, 520 East 70th Street, Starr 8, New York, NY, 10021, USA.
Alfons PompDivision of Metabolic and Bariatric Surgery, 520 East 70th Street, Starr 8, New York, NY, 10021, USA.
Enad DawodDivision of Gastroenterology and Hepatology, Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY, 10021, USA.
Shawn ShahDivision of Gastroenterology and Hepatology, Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY, 10021, USA.
Louis J AronneDivision of Endocrinology, Weill Cornell Medicine, 525 E. 68th Street, New York, NY, 10021, USA.
Reem Z SharaihaDivision of Gastroenterology and Hepatology, Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY, 10021, USA. rzs9001@med.cornell.edu.
Cornell University · USWeill Cornell Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEndoscopic sleeve gastroplasty (ESG) is a novel endobariatric procedure. Initial studies demonstrated an association of ESG with weight loss and improvement of obesity-related comorbidities. Our aim was to compare ESG to laparoscopic sleeve gastrectomy (LSG) and laparoscopic adjustable gastric banding (LAGB).

methodsWe included 278 obese (BMI > 30) patients who underwent ESG (n = 91), LSG (n = 120), or LAGB (n = 67) at our tertiary care academic center. Primary outcome was percent total body weight loss (%TBWL) at 3, 6, 9, and 12 months. Secondary outcome measures included adverse events (AE), length of stay (LOS), and readmission rate.

resultsAt 12-month follow-up, LSG achieved the greatest %TBWL compared to LAGB and ESG (29.28 vs 13.30 vs 17.57%, respectively; p < 0.001). However, ESG had a significantly lower rate of morbidity when compared to LSG or LAGB (p = 0.01). The LOS was significantly less for ESG compared to LSG or LAGB (0.34 ± 0.73 vs 3.09 ± 1.47 vs 1.66 ± 3.07 days, respectively; p < 0.01). Readmission rates were not significantly different between the groups (p = 0.72).

conclusionAlthough LSG is the most effective option for weight loss, ESG is a safe and feasible endobariatric option associated with low morbidity and short LOS in select patients.

Indexed as

Endoscopy, GastrointestinalLaparoscopyWeight LossAdolescentAdultAgedFemaleGastrectomyGastroplastyHumansLength of StayMaleMiddle AgedObesityPatient ReadmissionPostoperative ComplicationsEndoscopic sleeve gastroplastyLaparoscopic adjustable gastric bandLaparoscopic sleeve gastrectomyWeight loss

Identifiers

PMID29110192
OpenAlexW2767430429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.